INTRODUCTION
============

Endodontic treatment aims to prevent or control pulp and periapical infections. Due to the role of microorganisms in the pathogenesis of periradicular lesions, it is obvious that endodontic treatment outcomes depend on the reduction or elimination of microorganisms \[[@B1]\]. Bacteria invading the root canal system are responsible for the initiation and persistence of periapical diseases. Thus, elimination of bacteria from the root canal system is among the main goals of endodontic treatment \[[@B1][@B2][@B3]\]. The microbial count can be decreased by cleaning and shaping the root canal system, but cleaning and shaping cannot completely eliminate the bacteria lodged in the accessory canals. Thus, intracanal medicaments are recommended for use between treatment sessions to decrease the bacterial count in the root canal system \[[@B4][@B5][@B6]\]. Intracanal medicaments have several clinical applications, including management of traumatized teeth, treatment of teeth with extensive periapical lesions or inflammatory root resorption, and apexification and revascularization of permanent immature teeth \[[@B7]\]. Many intracanal medicaments cause tooth discoloration, especially when they remain in the tooth crown for a long period of time \[[@B8]\]. Tooth discoloration primarily occurs due to the penetration of materials into the dentinal tubules. Furthermore, it was shown that materials placed in the pulp chamber for long periods of time darkened the teeth over time \[[@B9]\]. Tooth discoloration due to the use of endodontic materials compromises esthetics. Therefore, endodontic treatment should not only focus on biological and practical aspects, but also take esthetics into account because tooth discoloration results in patient dissatisfaction \[[@B10]\].

Calcium hydroxide (CH) is extensively used as an intracanal material. This material has several favorable biological properties, such as antimicrobial activity, tissue-dissolving ability, prevention of tooth resorption, and induction of hard tissue barrier formation. Due to these characteristics, CH has several clinical applications. At present, this chemical agent is believed to be the most effective intracanal medicament for endodontic treatment \[[@B8][@B9]\]. Some studies have reported tooth discoloration, although insignificant, due to the application of CH \[[@B8][@B10][@B11][@B12]\]. Some additional materials have been incorporated into the formulation of CH to confer antibacterial properties or radiopacity; it has been suggested that these materials may result in tooth discoloration following the application of CH \[[@B10][@B13]\].

Chlorhexidine (CHX) has long been suggested for use as an intracanal medicament due to its broad-spectrum antimicrobial activity and substantivity. Previous studies have found that a mixture of CH and CHX had greater antibacterial efficacy than CH alone \[[@B14][@B15]\]. Enamel discoloration has been reported following the use of CHX mouthwash \[[@B16][@B17][@B18]\]; however, no study has evaluated tooth discoloration following the application of CHX combined with CH as an intracanal medicament.

Triple antibiotic paste (3Mix) (metronidazole, ciprofloxacin, and minocycline) has recently been used as an intracanal medicament for disinfection of root canals during endodontic treatment \[[@B9][@B10]\]. Studies on tooth discoloration following the use of 3Mix are scarce, but tooth discoloration following the use of this paste has been reported. Minocycline has also been found to cause significant discoloration in the tooth crown \[[@B9][@B19]\].

This study aimed to compare tooth discoloration following the application of different intracanal medicaments. Additionally, the effect of the location of intracanal medicament placement on coronal discoloration was evaluated.

MATERIALS AND METHODS
=====================

This study protocol was approved by the Institutional Ethical Committee (IRB No. IR.TUMS.IC.1392/1804). Human anterior maxillary teeth extracted for periodontal treatment were used in this study. The teeth were immersed in 0.5% sodium hypochlorite (NaOCl) solution for 30 minutes to eliminate the soft tissue debris and to disinfect the teeth. The teeth were then immersed in 0.5% chloramine-T solution (Merck, Darmstadt, Germany) and stored in dark conditions until the experiment.

Seventy single-rooted teeth with straight roots, no caries, no cracks or fractures, no resorption, a closed apex, and no cervical wear were included in this study. The calculus and debris were removed by a scaler and pumice paste and polishing cups. The teeth were inspected for cracks and resorption under a stereomicroscope (SM X800, Nikon Co., Melville, NY, USA). Radiographs were taken to ensure that the teeth had a single root canal. Standard access cavities were prepared using a round bur (Dentsply Maillefer, Ballaigues, Switzerland) and a fissure bur (d&z, Wiesbaden, Germany). A size 15 K-file (Mani Inc., Tochigi, Japan) was used for to determine the working length. The file was introduced into the canal until its tip was visible at the apex. One millimeter was subtracted from this length to yield the working length. Each canal was prepared with ProTaper rotary instrument (Dentsply Maillefer,) according to the manufacturer\'s instructions (S1, S2, F1, F2, F3, F4, and F5, respectively). RC-Prep (Premier Dental, Plymouth Meeting, PA, USA) was used as a lubricant and 10 mL of 2.5% NaOCl was used as an irrigant. The smear layer was eliminated using 1 mL of 17% ethylenediaminetetraacetic acid (Aria Dent, Tehran, Iran) and 1 mL of 5.25% NaOCl each for 3 minutes at the end of root canal preparation. The final rinse was done using 10 mL of normal saline. The apical foramen of each tooth was sealed with self-cured glass ionomer (Fuji Corporation, Tokyo, Japan). The teeth were then mounted in clear acrylic blocks (Acropars, Tehran, Iran) measuring 2 cm in length, 1 cm in width, and 4 cm in height in such a way that the apical two-thirds of the roots was embedded in acrylic resin ([Figure 1](#F1){ref-type="fig"}). Tiny squares measuring 1.5 × 1.5 mm were prepared at the mid-buccal surface of all teeth by a fissure bur (Dentsply Maillefer) to be used as a reference for repeated measurements.

![Specimen mounted in acrylic block.](rde-44-e10-g001){#F1}

Next, the teeth were randomly divided into 3 experimental groups (*n* = 20 each) and 1 control group (*n* = 10). The groups are shown in [Table 1](#T1){ref-type="table"}. In the control group, the canals were filled with saline and a cotton pellet was placed in the pulp chamber. Each experimental group was randomly divided into 2 subgroups of 10 (A and B). In subgroup A, we tried our best to apply the medicaments only to the root canals (below the cementoenamel junction), and a small cotton pellet was placed in the pulp chamber. In subgroup B, the canals were completely filled with the materials, and a cotton pellet was dipped in the medicaments and placed in the pulp chamber. The access cavity in all specimens was then restored with Cavit (3M ESPE, Seefeld, Germany). During the experiment, the teeth were in an upright position to prevent the flow of the medicaments in the root canal system towards the coronal portion of the teeth. All the teeth were kept in a dark glass jar, completely covered with a piece of cotton, and stored in an incubator at 37°C and 100% humidity.

###### Medicaments in the experimental and control groups
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  Group                                                  Material                                        Composition                                                                                                                    Manufacturer
  ------------------------------------------------------ ----------------------------------------------- ------------------------------------------------------------------------------------------------------------------------------ -----------------------------------------------
  Control (*n* = 10)                                     Normal saline                                   0.9% sodium chloride                                                                                                           Shahid Ghazi Pharmaceutical Co., Tabriz, Iran
  CH (*n* = 20)                                          Calcium hydroxide                               Calcium hydroxide--iodoform                                                                                                    Metapex; Meta Biomed Co., Cheongju, Korea
  CH/CHX (*n* = 20)                                      Calcium hydroxide paste and chlorhexidine gel   Calcium hydroxide was mixed with 2% chlorhexidine gel at a proportion of 1:1                                                   Metapex; Meta Biomed Co., Cheongju, Korea
  Gluco-Chex 2% gel; PPH Cerkamed, StalowaWola, Poland                                                                                                                                                                                  
  3Mix (*n* = 20)                                        Ciprofloxacin                                   Equal portions of metronidazole, ciprofloxacin, and minocycline mixed with distilled water (at a powder/liquid ratio of 3:1)   Bayer, Leverkusen, Germany
  Metronidazole                                          Braun, Melsungen, Germany                                                                                                                                                      
  Minocycline                                            Ratiopharm, Ulm, Germany                                                                                                                                                       

Color measurement
-----------------

Color assessments were done immediately after the placement of medicaments in the root canals (baseline=T0) and at 1 week (T1), 1 month (T2), and 3 months (T3) using the CIELAB color space. Spectral reflectance measurements were made using a spectrophotometer (CS-2000, Konica Minolta, Tokyo, Japan) and the obtained data were converted to color coordinates in D65/2^0^ geometry using Konica Minolta CS-S10w Professional Edition software (Konica Minolta Sensing Americas, Inc., Ramsey, NJ, USA). At each time of evaluation, the specimens were fixed on a jig, and color measurements were made at 20°C. Before each set of measurements, the spectrophotometer was calibrated according to the manufacturer\'s instructions. At each time point, 3 measurements were made of each specimen against a white background and the mean of the measurements was calculated. The light source illuminated the specimen surface at a 45° angle relative to the sample\'s perpendicular axis. The spectrophotoradiometer was adjusted at an angle of 0° relative to the sample\'s perpendicular axis at a distance of 70 cm from the specimens ([Figure 2](#F2){ref-type="fig"}). The viewing angle of the device was adjusted to 0.1°, yielding a circular measurement area with a 1.2 mm diameter at the center of the specimens\' crown.

![Positioning of the specimen, light source, and spectrophotometer.](rde-44-e10-g002){#F2}

The color change between different time points was calculated using the formula below \[[@B20]\]:
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Where *L*\* indicates lightness-darkness, *a*\* indicates redness-greenness, and *b*\* indicates yellowness-blueness of the samples \[[@B21]\].

Statistical analysis
--------------------

The *L*\*, *b*\*, and *a*\* parameters of the samples were measured and compared to the baseline values. In the experimental groups, Δ*E*\*, Δ*L*\*, Δ*b*\*, and Δ*a*\* were compared at different time points using 2-way analysis of variance (ANOVA). To compare the mean values of appearance changes caused by different medicaments, three-way ANOVA was performed on the Δ*E*\*,Δ*L*\*,Δ*b*\*, and Δ*a*\* parameters. The causes of differences were analyzed by *post hoc* ANOVA using the Scheffé method, and *p*-values \< 0.05 were considered to indicate statistical significance.

RESULTS
=======

The treatment groups did not have significant differences at baseline in the *L*\* (*p* = 0.05), *a*\* (*p* = 0.59), or *b*\* (*p* = 0.32) parameters. At 3 months, the 3Mix group showed the highest Δ*E*\* compared to other time points and medicaments. The Δ*E*\*, Δ*L*\*, Δ*a*\*, and Δ*b*\* values of different groups and subgroups (based on where the medicament was placed) at different time points are shown in [Tables 2](#T2){ref-type="table"}, [3](#T3){ref-type="table"}, [4](#T4){ref-type="table"}, [5](#T5){ref-type="table"}.

###### Mean Δ*E*\* values ± standard deviation of tooth samples from the different groups and at different time points
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  Group (subgroup)   1 week           1 month          3 months
  ------------------ ---------------- ---------------- -----------------
  CH (B)             1.8 ± 0.33^aA^   1.6 ± 0.30^aA^   2.1 ± 0.34^aA^
  CH (A)             1.9 ± 0.36^aA^   2.4 ± 0.54^aA^   2.3 ± 0.89^aA^
  CH/CHX (B)         1.8 ± 0.33^aA^   2.6 ± 0.68^aA^   3.2 ± 0.63^aA^
  CH/CHX (A)         1.4 ± 0.22^aA^   1.9 ± 0.43^aA^   1.8 ± 0.33^aA^
  3Mix (B)           5.0 ± 1.40^bA^   6.0 ± 1.40^bA^   12.0 ± 2.90^bA^
  3Mix (A)           3.1 ± 0.97^aA^   2.5 ± 0.83^aA^   5.3 ± 1.50^aA^
  Control            3.9 ± 0.65^aA^   5.0 ± 0.72^aA^   3.4 ± 0.63^aA^

The same uppercase letters in a row and the lowercase letters in a column indicate statistically similar groups (α = 0.05).

CH, alcium hydroxide; CHX, hlorhexidine; 3Mix, triple antibiotic paste (metronidazole, ciprofloxacin, and minocycline); A, subgroup in which medicaments were filled only into the canal (below the cementoenamel junction); B, subgroup in which the canals were completely filled with the materials, and a cotton pellet was dipped in the medicaments and placed in the pulp chamber.

###### Mean Δ*L*\* values ± standard deviation of tooth samples from the different groups and at different time points
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  Group (subgroup)   1 week              1 month            3 months
  ------------------ ------------------- ------------------ ------------------
  CH (B)             −0.29 ± 0.50^aA^    0.79 ± 0.25^aA^    −1.50 ± 0.35^aA^
  CH (A)             0.23 ± 0.36^aA^     0.98 ± 0.42^aA^    0.09 ± 0.52^aA^
  CH/CHX (B)         −0.024 ± 0.27^aA^   1.20 ± 0.58^aA^    −1.70 ± 0.65^aB^
  CH/CHX (A)         −0.05 ± 0.36^aA^    0.78 ± 0.51^aA^    −0.83 ± 0.50^aA^
  3Mix (B)           −0.81 ± 1.70^aA^    −3.40 ± 1.70^bA^   −8.90 ± 2.60^bB^
  3Mix (A)           −0.42 ± 1.20^aA^    −0.24 ± 1.00^aA^   −3.50 ± 1.60^aA^
  Control            3.30 ± 0.64^aA^     4.50 ± 0.61^aA^    1.50 ± 0.60^aA^

The same uppercase letters in a row and the same lowercase letters in a column indicate statistically similar groups (α = 0.05).

CH, alcium hydroxide; CHX, hlorhexidine; 3Mix, triple antibiotic paste (metronidazole, ciprofloxacin, and minocycline); A, subgroup in which medicaments were filled only into the canal (below the cementoenamel junction); B, subgroup in which the canals were completely filled with the materials, and a cotton pellet was dipped in the medicaments and placed in the pulp chamber.

###### Mean Δ*a*\* values ± standard deviation of tooth samples from the different groups and at different time points

![](rde-44-e10-i004)

  Group (subgroup)   1 week             1 month             3 months
  ------------------ ------------------ ------------------- ------------------
  CH (B)             −0.21 ± 0.16^aA^   0.35 ± 0.09^aB^     0.20 ± 0.12^aA^
  CH (A)             −0.55 ± 0.19^aA^   0.15 ± 0.19^aA^     −0.05 ± 0.32^aA^
  CH/CHX (B)         −0.46 ± 0.08^aA^   0.24 ± 0.16^aB^     0.12 ± 0.21^aA^
  CH/CHX (A)         −0.47 ± 0.09^aA^   0.56 ± 0.35^aB^     0.35 ± 0.09^aB^
  3Mix (B)           −1.10 ± 0.09^bA^   −0.031 ± 0.37^aA^   −0.32 ± 0.45^aA^
  3Mix (A)           −0.52 ± 0.22^aA^   −0.14 ± 0.26^aA^    −0.26 ± 0.42^aA^
  Control            −0.20 ± 0.09^aA^   0.43 ± 0.23^aB^     0.71 ± 0.23^aB^

The same uppercase letters in a row and the same lowercase letters in a column indicate statistically similar groups (α = 0.05).

CH, alcium hydroxide; CHX, hlorhexidine; 3Mix, triple antibiotic paste (metronidazole, ciprofloxacin, and minocycline); A, subgroup in which medicaments were filled only into the canal (below the cementoenamel junction); B, subgroup in which the canals were completely filled with the materials, and a cotton pellet was dipped in the medicaments and placed in the pulp chamber.

###### Mean Δ*b*\* values ± standard deviation of tooth samples from the different groups at different time points
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  Group (subgroup)   1 week             1 month            3 months
  ------------------ ------------------ ------------------ ------------------
  CH (B)             −0.21 ± 0.16^aA^   0.35 ± 0.09^aA^    0.20 ± 0.12^aA^
  CH (A)             −0.55 ± 0.19^aA^   0.15 ± 0.19^aA^    −0.05 ± 0.32^aA^
  CH/CHX (B)         −0.46 ± 0.08^aA^   0.24 ± 0.16^aA^    0.12 ± 0.21^aA^
  CH/CHX (A)         −0.47 ± 0.09^aA^   0.56 ± 0.35^aA^    0.35 ± 0.09^aA^
  3Mix (B)           −1.10 ± 0.09^aA^   −0.03 ± 0.37^aA^   −0.32 ± 0.45^bA^
  3Mix (A)           −0.52 ± 0.22^aA^   −0.14 ± 0.26^aA^   −0.26 ± 0.42^aA^
  Control            −0.20 ± 0.09^aA^   0.43 ± 0.23^aA^    0.71 ± 0.23^aA^

The same uppercase letters in a row and the same lowercase letters in a column indicate statistically similar groups (α = 0.05).

CH, alcium hydroxide; CHX, hlorhexidine; 3Mix, triple antibiotic paste (metronidazole, ciprofloxacin, and minocycline); A, subgroup in which medicaments were filled only into the canal (below the cementoenamel junction); B, subgroup in which the canals were completely filled with the materials, and a cotton pellet was dipped in the medicaments and placed in the pulp chamber.

The CH group showed no significant differences in Δ*E*\* at different time points (*p* = 0.7865). Furthermore, no difference with regard to where the medicament was placed was noted in the CH group (*p* = 0.2906). However, the Δ*L*\* values of the specimens showed significant differences across different time points (*p* = 0.0015), and also depending on the location of medicament placement (*p* = 0.0278). The Δ*E*\* in the group treated with a CH/CHX mixture showed no significant difference at different time points (*p* = 0.1367). However, when the medicament was placed in the pulp chamber, Δ*E* was significantly higher than when it was only applied to the root canal (*p* = 0.0377). Two-way ANOVA showed significant differences in Δ*L*\* among different time points (*p* = 0.0001), and the specimens became lighter over time; however, no significant difference in Δ*L*\* was found based on the location of medicament placement (*p* = 0.7132).

Analysis of the Δ*E*\* and Δ*L*\* values of the specimens treated with 3Mix showed significant differences across different time points (*p* = 0.0164 and *p* = 0.0044, respectively) and depending on the location of medicament placement (*p* = 0.0057 and *p* = 0.0380, respectively).

Three-way ANOVA showed significant differences among groups in terms of Δ*E*\* (*p* \< 0.0001). *Post hoc* analysis revealed that the 3Mix group had significant differences from other groups; but the difference in this regard between the CH and CH/CHX groups was not significant. Similar results were obtained with regard to the Δ*L*\* parameter among different medicaments, with the 3Mix group being much darker than the other 2 groups (*p* \< 0.0001).

DISCUSSION
==========

Misshapen or discolored teeth are among the main concerns for which adults, especially female patients and young individuals, seek esthetic dental treatments. Tooth discoloration can affect individuals\' self-confidence and social activities. In children, tooth discoloration can result in being mocked or bullied. Many patients undergoing root canal treatment are worried about the appearance of their teeth and possible postoperative discoloration \[[@B10]\].

Intracanal medicaments are used in many different ways in endodontics. For instance, in a necrotic tooth, CH is used as an intracanal medicament at a 1-week interval between treatment sessions for its antibacterial effects. CH is also used for apexification of immature teeth and during the monitoring of traumatized teeth for several weeks to months \[[@B22]\]. Other medicaments, such as 3Mix, are used in the root canal system for long periods of time in treatments such as revascularization \[[@B23]\]. Thus, tooth color assessments were done in the current study at multiple time intervals.

Colorimetry can be done visually or instrumentally. Visual colorimetry is performed using shade guides; which are extensively used by dentists. This analysis is influenced by the operator and the environment \[[@B10]\]. In contrast, spectrophotometry provides reliable, documented, high-quality, and reproducible colorimetric data \[[@B24]\]. Since the tooth surface is convex, not straight, a tele-spectrophotometer is preferred for color assessment. We used a CS2000 Konica Minolta spectrophotometer in the current study. This device is capable of making reproducible measurements from a non-straight surface \[[@B10][@B24]\].

Lenherr *et al.* \[[@B10]\] used extracted human teeth to assess color changes due to the application of endodontic materials. Similarly, we used extracted human teeth, since these teeth show the same patterns of color change as natural teeth in the oral cavity and better simulate clinical circumstances \[[@B10]\]. Similar to previous studies, a proper access cavity was prepared to allow placement of an adequate amount of material in the pulp chamber for a long period of time (3 months). The cavity was completely sealed to prevent extrusion of material through the access cavity \[[@B9]\].

Smear layer removal can affect the permeability of dentin, consequently influencing color change \[[@B9]\]. Kim *et al.* \[[@B9]\] reported that smear layer removal increased the color change of teeth. However, since recent disinfection protocols recommend smear layer removal to more efficiently clean the root canal system \[[@B9]\], the smear layer was removed in the current study.

The CIE L\*a\*b\* system was used for color assessment in the present study. According to this system, the *L*\* parameter indicates lightness; +*a*\* indicates redness and --*a*\* indicates greenness. The +*b*\* values indicate yellowness and −*b*\* values indicate blueness. Finally, Δ*E*\* shows the overall color change perceivable by the human eye \[[@B21]\].

CH as an intracanal medicament is marketed with different formulations, which can affect its discoloration potential \[[@B25][@B26]\]. Lenherr *et al.* \[[@B10]\], demonstrated that CH (ProduitsDentaires, SA, Vevey, Switzerland) alone and UltracalXS did not cause tooth discoloration after 12 weeks of application, and the changes in tooth color were not perceivable by the human eye. Moreover, Kim *et al.* \[[@B9]\], indicated that CH did not cause significant changes in tooth color compared to the control group, although CH resulted in yellowness and lightening of specimens. To explain this phenomenon, it has been proposed that the penetration of calcium ions into the dentinal tubules and their reaction with the hydroxyapatite crystals in the tubules result in lightening and yellowness of teeth medicated with CH \[[@B10][@B27]\]. In the present study, overall changes in tooth color did not occur and the color of teeth did not significantly change along the yellowness-blueness axis, but changes were noted in lightness. Similarly, Day *et al.* \[[@B28]\] reported an increase in the lightness of specimens. Changes in lightness may occur because a cotton pellet dipped in CH is darker than a plain cotton pellet, may help explain why lower lightness changes were observed after treatment with CH in subgroup B (crown) than in subgroup A (root). Considering the significant effect of time on the greenness-redness parameter, the change in the mean values in the groups responsible for the significant differences (T1 and T4) was only 0.6 units, which is lower than the perceivable color change by the human eye (3.7). In the present study, CH was used in the Metapex formulation, which has been shown not to cause significant discoloration as an intracanal medicament. Furthermore, this product is premixed and has a homogenous consistency, making it possible to place the CH paste in the same amount and density in all specimens \[[@B29][@B30]\].

In general, CH as a medicament did not cause any color change, in contrast to the 3Mix group, and the color change in this group was similar to that in the CH/CHX group.

In dentistry, CHX mouthwash is used for plaque control. Studies have shown that continuous use of CHX mouthwash results in tooth staining \[[@B31][@B32]\]. However, no study has shown that application of CHX gel as an intracanal medicament leads to tooth discoloration. In the present study, color changes occurred in the CH/CHX group both when a cotton pellet dipped in medicament was placed in the crown in subgroup B and when a cotton pellet without the medicament was used in subgroup A. The presence of a red tint in the specimens over time may have been due to the pink color of the CHX medicament, which shifts the color change towards redness in the red-green axis. This medicament was not significantly different from CH alone in terms of color change, but, it was significantly different from 3Mix \[[@B33]\].

Considering the increase in the reported cases of revascularization in the literature, 3Mix is often used for disinfection of root canals in these teeth. The greatest color change among the experimental groups in this study occurred in the 3Mix group; this color change in different studies has been attributed to the presence of minocycline in the composition of 3Mix \[[@B19]\]. Minocycline, a bacteriostatic agent, is derived from tetracycline \[[@B34]\]. When in direct contact with the tooth surface, it bonds to the calcium ions in dentin and forms an insoluble compound that results in tooth surface discoloration \[[@B28]\]. Discoloration starts in the first week and gradually increases with further penetration of the medicament until the tooth becomes completely dark. Similarly, Lenherr *et al.* \[[@B10]\], showed that the greatest color change occurred at 12 weeks. In another study, Kim *et al.* \[[@B27]\] demonstrated that 3Mix containing minocycline showed a greater color change than other 3Mix formulations, in which minocycline had been replaced with another antibiotic.

In a study by Kim *et al.* \[[@B9]\], color change due to the application of Ledermix as an intracanal medicament was evaluated. The results showed that its application led to tooth discoloration, and greater discoloration was found in the group where the medicament was placed in the pulp chamber than in the group where the medicament was placed only in the root canals \[[@B35]\]. The reason for this may be that coronal dentin is more permeable than root dentin. The antibiotic in Ledermix infiltrates into the dentinal tubules and bonds to dentin, resulting in tooth discoloration. In the current study, the cause of severe discoloration was the reaction of 3Mix with dentin, which led to tooth darkening following the use of this medicament. Its further penetration into the tubules over time is why the greatest discoloration was found after 3 months of treatment. The significant differences depending on where 3Mix was placed may have been due to the effect of direct placement of the medicament in the access cavity.

CONCLUSIONS
===========

The 3Mix medicament must be used for a short period of time to minimize tooth discoloration. It would also be better not to use 3Mix in teeth visible in the smile line. If 3Mix must be used in these teeth, care must be taken to limit its application to the root canal system, and the remaining paste in the pulp chamber must be thoroughly cleaned. Long-term use of a mixture of CH and CHX as an intracanal medicament does not compromise esthetics, but its application must be limited to the root canals.
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